Authenticating Art With Bioengineered DNA: The IP Issues

Law360, New York (November 2, 2015, 11:43 AM EST) -- Recently making the rounds in the media circuit are reports on a fascinating new authentication system that would allow living artists to effectively "sign" their artworks with very small amounts of synthetic DNA.[1] This new authentication system is encompassed more broadly within "i2M," a new standards-based technology that is uniquely developed to provide an industrywide solution to the long-standing problem of faked, forged and stolen art in the art world.[2] This article provides an overview of the i2M Standards and addresses the legal implications of the i2M Standards technology from an intellectual property perspective....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!